Eplerenone is an aldosterone receptor antagonist and potassium-sparing diuretic used in the therapy of hypertension and congestive heart failure (1, 3). Eplerenone is indicated to improve survival of stable patients with left ventricular systolic dysfunction (ejection fraction of 40% or below) and clinical evidence of congestive heart failure (HF) after an acute myocardial infarction (MI). Eplerenone is also indicated for the treatment of hypertension alone or in combination with other antihypertensive agents.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API).
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL monograph for Eplerenone, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.